Orbit Discovery competitorsClear all

Orbit Discovery's top competitors include Moderna Therapeutics, Bristol-Myers Squibb, GlaxoSmithKline and BioPorto.
Orbit Discovery
Orbit Discovery
Orbit Discovery is a peptide display technology company that identifies peptide drugs for chronic diseases.
Moderna Therapeutics
Moderna Therapeutics
Moderna Therapeutics develops messenger RNA therapeutics that produces human proteins for antibodies inside patient cells.
Bristol-Myers Squibb
Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company focused on discovering, developing and delivering innovative medicines for patients with serious and life-threatening diseases.
GlaxoSmithKline
GlaxoSmithKline
GlaxoSmithKline is a science-led healthcare company.
BioPorto
BioPorto
BioPorto develops and markets antibodies and antibody-based products, including tests to diagnose human disease, both for the benefit of individual patients.
Founding Date
Founding Date
2015
Founding Date
N/A
Founding Date
1887
Founding Date
2000
Founding Date
2000
Type
Type
Private
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Oxford, GB HQ
Locations
Cambridge, US HQ
Huddinge, SE
Cambridge, US
Norwood, US
Chicago, US
Huntington, US
Locations
New York, US HQ
Braine L'alleud, BE
Montréal, CA
Montréal, CA
Pudong Xinqu, CN
Virum, DK
Espoo, FI
see more
Locations
Brentford, GB HQ
Tiranë, AL
Minsk, BY
Las Condes, CL
Bogotá, CO
Sabanilla, CR
San José, CR
see more
Locations
Hellerup, DK HQ
Employees
Employees
29
Employees
76012% increase
Employees
23,3002% decrease
Employees
98,462
Employees
26
Valuation ($)
Valuation ($)
N/A
Valuation ($)
5.2 b
Valuation ($)
75.3 b
Valuation ($)
101.9 b
Valuation ($)
N/A
Twitter followers
Twitter followers
N/A
Twitter followers
3.8 k
Twitter followers
134.7 k
Twitter followers
185.1 k
Twitter followers
N/A
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
23
Number of tweets (last 30 days)
32
Number of tweets (last 30 days)
47
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
4
Average likes per tweet (last 30 days)
13.8
Average likes per tweet (last 30 days)
29.8
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
95.65%
Percentage of tweets with engagement (last 30 days)
96.88%
Percentage of tweets with engagement (last 30 days)
72.34%
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
315418
Alexa Website Rank
329468
Alexa Website Rank
170410
Alexa Website Rank
43642
Alexa Website Rank
172077

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$135.1m (FY, 2018)
Revenue (est.)
$22.6b (FY, 2018)
Revenue (est.)
£30.8b (FY, 2018)
Revenue (est.)
N/A
Net income
Net income
N/A
Net income
($384.7m) (FY, 2018)
Net income
$4.9b (FY, 2018)
Net income
£4b (FY, 2018)
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 9.4m
Total funding raised
$ 1.8b
Total funding raised
$ 15.5m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

Moderna Therapeutics
HQ
Cambridge, US
Employees
760↑ 12% increase

Moderna Therapeutics develops messenger RNA therapeutics that produces human proteins for antibodies inside patient cells.

View company
Bristol-Myers Squibb
HQ
New York, US
Employees
23,300↓ 2% decrease

Bristol-Myers Squibb is a global biopharmaceutical company focused on discovering, developing and delivering innovative medicines for patients with serious and life-threatening diseases.

View company
GlaxoSmithKline
HQ
Brentford, GB
Employees
98,462

GlaxoSmithKline is a science-led healthcare company.

View company
BioPorto
HQ
Hellerup, DK
Employees
26

BioPorto develops and markets antibodies and antibody-based products, including tests to diagnose human disease, both for the benefit of individual patients.

View company